Bluma Wellness Inc. (the “Company” or “Bluma Wellness”) (CSE: BWEL.U) is pleased to announce that its subsidiary company, One Plant Florida (“One Plant”), has opened its seventh retail dispensary and delivery hub location in Fern Park, Florida.
Situated in the heart of Seminole County in the greater Orlando area, One Plant’s Fern Park retail dispensary and delivery hub is located at 134 Fernwood Blvd., Fern Park, FL 32730. The new location will serve qualified patients in Fern Park and throughout Orange County via delivery.
This location will offer access to One Plant’s top-shelf genetics, hang-dried and hand-trimmed flower, vape products, concentrates and merchandise through an in-store experience, curbside pickup or home delivery. Offerings include prime and rare strains of cannabis flower and pre rolls including Mac1, Runtz, London Pound Cake, Blueberry Muffin, Dirty Lemons, ChemD, Fish Whistle, Apple Fritter, Marshmallow OG, Watermelon Gushers, and I75, among others. One Plant also offers premium solventless ice hash products including live rosin, bubble hash, live rosin jam, fresh press jam, live rosin vaporizer cartridges, as well as traditional distillate products including vaporizer cartridges, tinctures, and topicals.
The company’s retail sites are carefully selected to promote efficient delivery of premium flower to Florida’s patients. One Plant Florida expects to open its eighth retail dispensary and delivery hub location in Florida in North Miami in January 2021.
“We are proud to end a busy year of store openings in 2020 with the opening of our Fern Park (Orlando) dispensary and delivery hub, which is our seventh (7th) store opened to date,” said Brady Cobb, Chief Executive Officer of Bluma Wellness.
One Plant cultivates, processes, dispenses and retails medical cannabis to qualified patients in the State of Florida through multiple retail dispensaries and an innovative next-day door-to-door e-commerce home delivery service.
To utilize One Plant’s robust delivery and curbside options at its retail locations, orders can be placed online, and patients can use CanPay for payment. A loyalty rewards program is offered as well. Patients must have a medical marijuana card to purchase products.
Qualified patients can learn more about the Company’s retail dispensary locations by visitingwww.oneplant.us.
About Bluma Wellness Inc.: Bluma Wellness Inc. owns and operates a vertically-integrated, licensed medical cannabis company in the State of Florida doing business as “One Plant Florida.” One Plant Florida cultivates, processes, dispenses and retails medical cannabis to qualified patients in the State of Florida through multiple retail dispensaries and an innovative next-day door-to-door e-commerce home delivery service, thereby offering convenient access for its patients and meeting the demands of an evolving retail landscape. Bluma plans to continue expanding its cultivation and distribution operations as the Florida market grows and may enter into other US states where the production, distribution and use of cannabis is permitted under state law. For more information, visit www.blumawellness.com orwww.oneplant.us.
The Company’s securities have not been and will not be registered under the U.S. Securities Act and may not be offered or sold in the United States or to a U.S. Person absent registration or an applicable exemption from the registration requirement. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.
This news release contains “forward-looking information” within the meaning of applicable Canadian securities laws including information relating to the opening of One Plant’s Fern Park retail and delivery hub and the Company’s strategic business plans. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements due to a variety of known and unknown risks and uncertainties including, without limitation: risks relating to cannabis being illegal under US federal law and risks of US federal enforcement actions related to cannabis activities; the Company’s ability to comply with all applicable governmental regulations in a highly regulated business; negative changes in the political environment or in the regulation of medical cannabis in the state of Florida; the risk of any disruptions to the Company’s business and operations as a result of the COVID-19 pandemic; negative shifts in public opinion and perception of the cannabis industry and cannabis consumption; increasing competition in the industry; risks of product liability and other safety-related liability as a result of usage of the Company’s cannabis products; the Company’s limited operating history with no assurance of profitability; the ability of the Company to access future financing if needed or on terms acceptable to the Company; the risk of defaulting on its existing debt; risk of shortages of or price increases in key inputs, suppliers and skilled labor; the risks inherent in running agricultural operations such as pests and crop failure; loss of licenses; reliance on key personnel; cybersecurity risks; constraints on marketing products; fraudulent activity by employees, contractors and consultants; tax and insurance related risks and risk of litigation.
The forward-looking information in this press release are made as of the date of this release. The Company does not undertake any obligation to update forward-looking information except as required by applicable securities laws.